Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2021

Biotek-snakken — Oktober 2021

Planlagt Fastgjort Låst Flyttet Biotek-snakken
168 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #107

    Link Preview Image
    Wells Fargo: These 3 Stocks Are Poised to Surge by at Least 40%

    Inflation worries seem to be at the forefront of investors’ concerns right now. However, Mark Smith, senior vice president and portfolio manager at Wells Fargo Advisors, has a solution to put investors at ease: “One of the best ways to combat inflation is through buying equities.” The reopening is “on strong,” people have more money than they ever had, and the banks have kicked off the latest earnings season in style - all are reasons to be “extremely bullish," according to Smith. With this in m

    favicon

    Yahoo Finance (finance.yahoo.com)

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #108

      Cantargia rapporterar behandling av första patienten i kliniska studien CESTAFOUR

      1 Reply Last reply
      0
      • B Offline
        B Offline
        BioShare
        wrote on sidst redigeret af
        #109

        Tak Sukkeralf - men lige lidt hjælper det. Det vender forhåbentlig rundt. God weekend hele vejen rundt 🙂

        1 Reply Last reply
        0
        • R Offline
          R Offline
          Rasbom
          wrote on sidst redigeret af
          #110

          Fandel det hjalp desværre ikke meget på kursen. Det ser ud til en hver nyhed bare benyttes til at øge udsalget….

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #111

            Netop opskriften på at gøre små investorer trætte af aktien. Hold ud 🙂

            1 Reply Last reply
            0
            • F Offline
              F Offline
              Fandel
              wrote on sidst redigeret af
              #112

              Godmorgen...

              1 Reply Last reply
              0
              • D Offline
                D Offline
                DevOp
                wrote on sidst redigeret af
                #113

                ATNF: CEO Jim Woody forventer at kunne offentliggøre resultater for Dupuytrens's i Dec (måske 10. dec? :-)) og spændende nyt samarbejde med Celltrion

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #114

                  Best Stocks To Invest In Right Now? 3
                  Health Care Stocks To Watch https://www.proinvestor.com/investornyt/722665/best-stocks-to-invest-in-right-now-3-health-care-stocks-to-watch

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #115

                    2 Biotech Stocks That Could Go Parabolic This Week https://www.proinvestor.com/investornyt/722667/2-biotech-stocks-that-could-go-parabolic-this-week

                    1 Reply Last reply
                    0
                    • F Offline
                      F Offline
                      Fandel
                      wrote on sidst redigeret af
                      #116

                      Godmorgen...

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Pharmafar
                        wrote on sidst redigeret af
                        #117

                        Link Preview Image
                        Novartis top-line results for CANOPY-1 Phase III study support further evaluation of canakinumab in lung cancer

                        favicon

                        Novartis (www.novartis.com)

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          LP90
                          wrote on sidst redigeret af
                          #118

                          er det shorts der sættes i Cantargia skal godt nok love for den er blevet trykket ned den sidste lange tid ?

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Rasbom
                            wrote on sidst redigeret af
                            #119

                            Novartis fejler Igen med Canakinomab. Der bliver helt sikkert ikke meget at juble over som Cantargia aktionær i dag.

                            1 Reply Last reply
                            0
                            • R Offline
                              R Offline
                              Rasbom
                              wrote on sidst redigeret af
                              #120

                              reuters.com

                              favicon

                              (www.reuters.com)

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                LP90
                                wrote on sidst redigeret af
                                #121

                                Rasbom Cantargias can 04 og can 10 kan man vel ikke bare sammenligne med med Novartis eller ?

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #122

                                  IL-1rap er en bredere virkningsmekanisme (hæmmer både Il-1 alfa og IL-1 beta, men stadig ikke godt at Novartis fejler med IL-1 beta

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #123

                                    Problemet bliver nok, at ind til der er kørt store randomiserede studier med IL-1 rap altid vil herske en vis usikkerhed. Can 10 sigter dog mod helt andre indikationer, så værdien af dette asset burde ikke berøres sønderligt

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #124

                                      altså usikkerhed i cancer

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        LP90
                                        wrote on sidst redigeret af
                                        #125

                                        Sukkeralf tak for dit svar du virker som om du er fagmand med stort tak

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #126

                                          Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma

                                          https://www.evaxion-biotech.com/news-and-events/press-releases/news-details/2021/Evaxion-Biotech-Announces-Clinical-Collaboration-to-Evaluate-Lead-Product-Candidate-with-KEYTRUDA-pembrolizumab-in-Patients-with-Melanoma/

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper